Related Experiment Video
Updated: Sep 28, 2025

Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
Neuroprotection by Mucuna pruriens in Neurodegenerative Diseases
Walia Zahra1, Hareram Birla1, Saumitra Sen Singh1
1Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.
Abstract:
The medicinal plant Mucuna pruriens (Fabaceae) is widely known for its anti-oxidative and anti-inflammatory properties. It is a well-established drug in Ayurveda and has been widely used for the treatment of neurological disorders and male infertility for ages. The seeds of the plant have potent medicinal value and its extract has been tested in different models of neurodegenerative diseases, especially Parkinson's disease (PD). Apart from PD, Mucuna pruriens is now being studied in models of other nervous systems disorders such as Alzheimer's disease (AD), Amyotrophic lateral sclerosis (ALS) and stroke because of its neuroprotective importance. This review briefly discusses the pathogenesis of PD, AD, ALS and stroke. It aims to summarize the medicinal importance of Mucuna pruriens in treatment of these diseases, and put forward the potential targets where Mucuna pruriens can act for therapeutic interventions. In this review, the effect of Mucuna pruriens on ameliorating the neurodegeneration evident in PD, AD, ALS and stroke is briefly discussed. The potential targets for neuroprotection by the plant are delineated, which can be studied further to validate the hypothesis regarding the use of Mucuna pruriens for the treatment of these diseases.
Insights
Mucuna pruriens seeds show promise for treating neurodegenerative diseases like Parkinson's disease (PD), Alzheimer's disease (AD), Amyotrophic lateral sclerosis (ALS), and stroke. Research highlights its neuroprotective potential and identifies therapeutic targets for these conditions.
Area of Science:
- Pharmacology and Ethnobotany
- Neuroscience and Neurodegenerative Diseases
Background:
- Mucuna pruriens (Fabaceae) is a medicinal plant recognized for its antioxidant and anti-inflammatory properties.
- It holds a significant place in Ayurvedic medicine, traditionally used for neurological disorders and male infertility.
- The plant's seeds are particularly valued for their potent medicinal properties.
Purpose of the Study:
- To review the pathogenesis of Parkinson's disease (PD), Alzheimer's disease (AD), Amyotrophic lateral sclerosis (ALS), and stroke.
- To summarize the medicinal importance of Mucuna pruriens in treating these neurodegenerative conditions.
- To identify potential therapeutic targets for Mucuna pruriens in neuroprotection.
Main Methods:
- Literature review focusing on the pathogenesis of PD, AD, ALS, and stroke.
- Analysis of studies investigating Mucuna pruriens extract in various neurodegenerative disease models.
- Discussion of the neuroprotective effects and potential mechanisms of action of Mucuna pruriens.
Main Results:
- Mucuna pruriens extract has demonstrated efficacy in preclinical models of neurodegenerative diseases.
- The plant's extract shows potential in ameliorating neurodegeneration associated with PD, AD, ALS, and stroke.
- Key targets for Mucuna pruriens' neuroprotective activity have been identified.
Conclusions:
- Mucuna pruriens exhibits significant neuroprotective potential against a range of neurodegenerative disorders.
- Further research into the identified therapeutic targets can validate its use in clinical settings.
- Mucuna pruriens represents a promising natural therapeutic agent for neurological conditions.
More Related Videos
09:44Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
08:53Assessing Neuroprotective Effects of Glycyrrhizae Radix et Rhizoma Extract Using a Transient Middle Cerebral Artery Occlusion Mouse Model
Published on: December 9, 2018
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
The Blood-brain Barrier
Drugs Affecting Neurotransmitter Synthesis